Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular imaging in prostate cancer.

Jose A Karam1, Ralph P Mason, Kenneth S Koeneman

  • 1Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9110, USA.

Journal of Cellular Biochemistry
|October 3, 2003
PubMed
Summary

New molecular imaging techniques offer non-invasive ways to detect early prostate cancer (PCa) and aid in diagnosis and prognosis. These methods visualize molecular changes, improving patient outcomes and reducing morbidity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling" [Cellular Signaling, 2015 Sep 26; 27(12): 2515-2523].

Cellular signalling·2026
Same author

Study of benign prostatic hyperplasia and androgen pathway manipulation on lung cancer survivals.

Journal of advanced research·2026
Same author

Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

The New England journal of medicine·2026
Same author

Divergent biology and outcomes of somatic transformations in germ cell tumors.

The oncologist·2026
Same author

5x-Multiplier Versus 3-Tier Model: A Pragmatic Randomized Clinical Trial for Discharge Opioid Prescriptions After Intra-Abdominal Cancer Surgery.

Annals of surgery·2026
Same author

Renal Medullary Carcinoma: Utility of [<sup>18</sup>F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Area of Science:

  • Oncology
  • Medical Imaging

Background:

  • Prostate cancer (PCa) is a leading non-cutaneous malignancy in men, necessitating improved early diagnostic methods.
  • Tumorigenesis and metastasis involve unique genetic and biochemical cellular alterations.
  • Molecular imaging aims to detect these pathological processes at the cellular level.

Purpose of the Study:

  • To review current and emerging molecular imaging modalities for prostate cancer detection.
  • To highlight the potential of these techniques for early diagnosis, follow-up, and prognosis.

Main Methods:

  • Review of established molecular imaging techniques including Positron Emission Tomography (PET), Magnetic Resonance Spectroscopic Imaging (MRSI), Magnetic Resonance Imaging (MRI), and radiolabeled antibodies.
  • Discussion of emerging techniques such as Bioluminescence Imaging (BLI), tumor oxygenation measurement, and iodine uptake measurement.

Related Experiment Videos

Main Results:

  • Established modalities like PET and MRI can detect abnormal tumor metabolic processes in clinical settings.
  • Emerging techniques show promise for future applications in prostate cancer detection.
  • These imaging approaches are non-invasive, potentially reducing patient morbidity.

Conclusions:

  • Molecular imaging offers a promising avenue for the early detection, accurate follow-up, and prognostic assessment of prostate cancer.
  • Non-invasive imaging techniques can significantly improve patient care by minimizing undue morbidity.
  • Continued development of novel imaging modalities is crucial for advancing prostate cancer diagnostics.